Income Statement WuXi AppTec Co., Ltd.

Equities

603259

CNE1000031K4

Biotechnology & Medical Research

End-of-day quote Shanghai S.E. Other stock markets 09/09/2024			5-day change	1st Jan Change
39.41 ^CNY	+1.57%		+4.43%	-45.84%

05:07am	WuXi AppTec Asserts It is Not a Security Risk Following Passage of Biosecure Bill in US Congress	MT
03:48am	WuXi Companies Reaffirm No Security Risk as U.S. House Passes Draft Biosecure Act	DJ

ce50b7d.BnDpm7nl_HT6TK5UoIjUhDn88KwOdb4WhZvJvUHmBC4.azWKydO0kRCUItwFkNKZtnatkfx2Nolg5Om9yzigVkJuILP6ib2SLbV_wQ

Published financial data: WUXI APPTEC CO., LTD.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2019	2020	2021	2022	2023
Revenues	12.85B	16.51B	22.87B	39.32B	40.3B
Other Revenues, Total	21.22M	22.1M	27.52M	33.61M	41.05M
Total Revenues	12.87B	16.54B	22.9B	39.35B	40.34B
Cost of Goods Sold, Total	7.86B	10.27B	14.63B	24.72B	23.77B
Gross Profit	5.01B	6.26B	8.28B	14.64B	16.57B
Selling General & Admin Expenses, Total	1.92B	2.43B	2.9B	3.56B	3.58B
Provision for Bad Debts	43.17M	12.63M	31.61M	117M	241M
R&D Expenses	590M	693M	942M	1.61B	1.44B
Other Operating Expenses	28.16M	34.5M	53.58M	200M	297M
Other Operating Expenses, Total	2.58B	3.17B	3.93B	5.49B	5.56B
Operating Income	2.43B	3.1B	4.35B	9.15B	11.02B
Interest Expense, Total	-128M	-196M	-128M	-160M	-194M
Interest And Investment Income	136M	699M	1.55B	379M	678M
Net Interest Expenses	7.74M	503M	1.42B	219M	485M
Currency Exchange Gains (Loss)	20.67M	-411M	-139M	264M	108M
Other Non Operating Income (Expenses)	-4.82M	-5.02M	-8.21M	-46.55M	-21.22M
EBT, Excl. Unusual Items	2.45B	3.18B	5.62B	9.58B	11.59B
Impairment of Goodwill	-	-44.35M	-	-131M	-49.61M
Gain (Loss) On Sale Of Investments	-259M	52.27M	-93.39M	770M	-37.81M
Gain (Loss) On Sale Of Assets	-7.41M	-25.74M	239M	-34.78M	-78.81M
Asset Writedown	-	-1.67M	-	-9.88M	-67.4M
Other Unusual Items	150M	206M	250M	442M	477M
EBT, Incl. Unusual Items	2.34B	3.37B	6.02B	10.62B	11.83B
Income Tax Expense	426M	383M	880M	1.72B	2.13B
Earnings From Continuing Operations	1.91B	2.99B	5.14B	8.9B	9.7B
Net Income to Company	1.91B	2.99B	5.14B	8.9B	9.7B
Minority Interest	-56.86M	-26.01M	-38.79M	-88.9M	-93.51M
Net Income - (IS)	1.85B	2.96B	5.1B	8.81B	9.61B
Preferred Dividend and Other Adjustments	-	6.62M	-	-	-
Net Income to Common Incl Extra Items	1.85B	2.95B	5.1B	8.81B	9.61B
Net Income to Common Excl. Extra Items	1.85B	2.95B	5.1B	8.81B	9.61B
Per Share Items
Net EPS - Basic	0.68	1.06	1.75	3.01	3.27
Basic EPS - Continuing Operations	0.68	1.06	1.75	3.01	3.27
Basic Weighted Average Shares Outstanding	2.73B	2.79B	2.91B	2.93B	2.94B
Net EPS - Diluted	0.67	1.05	1.73	2.82	3.24
Diluted EPS - Continuing Operations	0.67	1.05	1.73	2.82	3.24
Diluted Weighted Average Shares Outstanding	2.78B	2.82B	2.95B	3.13B	2.97B
Normalized Basic EPS	0.54	0.7	1.19	2.01	2.43
Normalized Diluted EPS	0.53	0.7	1.18	1.89	2.41
Dividend Per Share	0.2	0.3	0.52	0.89	0.99
Payout Ratio	39.39	21.56	17.91	18.14	28.69
American Depositary Receipts Ratio (ADR)	1	1	1	1	1
Supplemental Items
EBITDA	3.09B	3.88B	5.38B	10.59B	13.01B
EBITA	2.47B	3.14B	4.42B	9.24B	11.1B
EBIT	2.43B	3.1B	4.35B	9.15B	11.02B
EBITDAR	3.11B	3.9B	5.4B	10.6B	13.02B
Total Revenues (As Reported)	12.87B	-	22.9B	39.35B	40.34B
Effective Tax Rate - (Ratio)	18.21	11.37	14.62	16.16	18.02
Total Current Taxes	452M	513M	903M	1.65B	1.91B
Total Deferred Taxes	-16.14M	-88.84M	-39.95M	48.31M	233M
Normalized Net Income	1.48B	1.96B	3.47B	5.9B	7.15B
Interest on Long-Term Debt	45.68M	54.2M	60.22M	52.34M	53.6M
Supplemental Operating Expense Items
Advertising Expense	31.82M	26.02M	34.11M	50.99M	54.44M
Selling and Marketing Expenses	435M	580M	695M	730M	697M
General and Administrative Expenses	1.48B	1.84B	2.2B	2.83B	2.88B
Research And Development Expense From Footnotes	590M	693M	942M	1.61B	1.44B
Net Rental Expense, Total	24.25M	19.03M	18.83M	18.62M	17.39M
Imputed Operating Lease Interest Expense	8.52M	5.98M	4.51M	4.69M	4.66M
Imputed Operating Lease Depreciation	15.73M	13.06M	14.33M	13.93M	12.73M
Stock-Based Comp., Other (Total)	195M	665M	639M	841M	750M
Total Stock-Based Compensation	195M	665M	639M	841M	750M

Fiscal Period: December	2019	2020	2021	2022	2023
Assets
Cash And Equivalents	5.23B	10.24B	8.24B	7.99B	13.76B
Short Term Investments	-	-	-	1.43B	786M
Trading Asset Securities, Total	1.7B	4.62B	527M	2M	11M
Total Cash And Short Term Investments	6.93B	14.86B	8.77B	9.42B	14.56B
Accounts Receivable, Total	3.34B	4.21B	5.44B	7.1B	9.16B
Other Receivables	21.5M	26.63M	325M	71.36M	168M
Total Receivables	3.36B	4.24B	5.77B	7.17B	9.32B
Inventory	1.74B	2.69B	5.91B	5.67B	4.74B
Other Current Assets, Total	629M	1.28B	1.55B	1.75B	1.8B
Total Current Assets	12.66B	23.06B	21.99B	24B	30.42B
Gross Property Plant And Equipment	11.04B	14.23B	21.08B	29.89B	34.83B
Accumulated Depreciation	-3.11B	-3.9B	-4.96B	-6.31B	-8.26B
Net Property Plant And Equipment	7.93B	10.32B	16.13B	23.58B	26.58B
Long-term Investments	4.8B	7.48B	11.49B	10.91B	10.84B
Goodwill	1.36B	1.39B	1.93B	1.82B	1.82B
Other Intangibles, Total	918M	998M	1.6B	1.78B	1.86B
Deferred Tax Assets Long-Term	262M	301M	390M	492M	367M
Deferred Charges Long-Term	1.25B	1.36B	1.54B	1.81B	1.68B
Other Long-Term Assets, Total	50.33M	1.38B	65.08M	288M	98.15M
Total Assets	29.24B	46.29B	55.13B	64.69B	73.67B
Liabilities
Accounts Payable, Total	1.52B	2.36B	4.16B	3.97B	3.77B
Accrued Expenses, Total	1.83B	2.11B	2.48B	3B	3.25B
Short-term Borrowings	1.6B	1.23B	2.26B	3.87B	3.67B
Current Portion of Long-Term Debt	206M	712K	176M	22.09M	-
Current Portion of Leases	142M	177M	220M	205M	240M
Current Income Taxes Payable	261M	340M	459M	518M	992M
Unearned Revenue Current, Total	897M	1.58B	2.99B	2.5B	1.96B
Other Current Liabilities	174M	125M	237M	416M	878M
Total Current Liabilities	6.63B	7.92B	12.98B	14.5B	14.76B
Long-Term Debt	2.64B	1.82B	607M	781M	687M
Long-Term Leases	1.1B	1.07B	1.02B	984M	1.1B
Unearned Revenue Non Current	667M	682M	771M	911M	1.08B
Deferred Tax Liability Non Current	231M	283M	324M	440M	530M
Other Non Current Liabilities	555M	1.8B	664M	148M	-
Total Liabilities	11.83B	13.57B	16.37B	17.76B	18.15B
Common Stock, Total	1.65B	2.44B	2.96B	2.96B	2.97B
Additional Paid In Capital	10.29B	22.68B	25.73B	26.51B	28.4B
Retained Earnings	5.92B	8.33B	12.53B	19.84B	26.8B
Treasury Stock	-706M	-1.19B	-2.46B	-2.75B	-3.16B
Comprehensive Income and Other	156M	237M	-271M	24M	112M
Total Common Equity	17.31B	32.49B	38.49B	46.59B	55.12B
Minority Interest	97.45M	225M	266M	337M	395M
Total Equity	17.41B	32.72B	38.76B	46.93B	55.52B
Total Liabilities And Equity	29.24B	46.29B	55.13B	64.69B	73.67B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	2.77B	2.93B	2.96B	2.96B	2.97B
ECS Total Common Shares Outstanding	2.77B	2.93B	2.96B	2.96B	2.97B
Book Value / Share	6.24	11.09	13.02	15.74	18.57
Tangible Book Value	15.03B	30.1B	34.97B	42.98B	51.44B
Tangible Book Value Per Share	5.42	10.27	11.83	14.52	17.33
Total Debt	5.69B	4.29B	4.28B	5.87B	5.69B
Net Debt	-1.24B	-10.56B	-4.48B	-3.55B	-8.87B
Debt Equivalent Oper. Leases	194M	152M	151M	149M	139M
Minority Interest, Total (Incl. Fin. Div)	97.45M	225M	266M	337M	395M
Equity Method Investments, Total	794M	765M	678M	1.2B	2.22B
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	788M	1.08B	1.89B	2.47B	2.36B
Inventories - Work In Process, Total	642M	987M	2.79B	2.24B	1.52B
Inventories - Finished Goods, Total	326M	653M	1.29B	1.06B	1B
Buildings, Total	2.28B	2.85B	3.87B	5.79B	7.69B
Machinery, Total	5.01B	6.45B	9.13B	14.03B	16.93B
Full Time Employees	21.74K	-	34.91K	44.36K	41.12K
Accumulated Allowance for Doubtful Accounts (Supple)	67.57M	77.39M	103M	160M	373M

Fiscal Period: December	2019	2020	2021	2022	2023
Net Income	1.85B	2.96B	5.1B	8.81B	9.61B
Depreciation & Amortization - CF	770M	924M	1.17B	1.55B	2.13B
Amortization of Goodwill and Intangible Assets - (CF)	38.54M	48.89M	77.18M	89.02M	87.58M
Depreciation & Amortization, Total	809M	973M	1.25B	1.64B	2.21B
Amortization of Deferred Charges, Total - (CF)	155M	171M	234M	278M	299M
(Gain) Loss From Sale Of Asset	2.61M	25.74M	-264M	11.16M	33.45M
(Gain) Loss on Sale of Investments - (CF)	129M	-1.14B	-1.63B	245M	249M
Asset Writedown & Restructuring Costs	-152K	-246M	-606M	-510M	-236M
Stock-Based Compensation (CF)	-	557M	-	-	-
Provision and Write-off of Bad Debts	43.17M	12.63M	31.61M	117M	241M
Other Operating Activities, Total	274M	1.23B	1.13B	-584M	97.9M
Change In Accounts Receivable	-981M	-1.28B	-1.83B	-1.98B	-2.14B
Change In Inventories	-511M	-1.04B	-2.99B	499M	978M
Change In Accounts Payable	996M	1.83B	3.67B	1.18B	1.06B
Change In Deferred Taxes	-26.91M	-77.93M	-57.85M	44.87M	233M
Change in Other Net Operating Assets	173M	-	557M	859M	756M
Cash from Operations	2.92B	3.97B	4.59B	10.62B	13.39B
Capital Expenditure	-2.53B	-3.03B	-6.94B	-9.97B	-5.52B
Sale of Property, Plant, and Equipment	15.85M	8.59M	1.81M	298M	16.12M
Cash Acquisitions	-785M	-186M	-858M	-161M	-22.09M
Divestitures	-	-	-	-21.19M	-
Investment in Marketable and Equity Securities, Total	-1.79B	-5.64B	2.77B	81.64M	-2.32B
Other Investing Activities, Total	118M	70.77M	187M	78.8M	283M
Cash from Investing	-4.97B	-8.78B	-4.84B	-9.69B	-7.56B
Short Term Debt Issued, Total	-	-	2.28B	-	-
Long-Term Debt Issued, Total	4.93B	1.69B	-	3.33B	6.84B
Total Debt Issued	4.93B	1.69B	2.28B	3.33B	6.84B
Short Term Debt Repaid, Total	-	-	-1.21B	-	-
Long-Term Debt Repaid, Total	-578M	-3.21B	-246M	-1.91B	-6.98B
Total Debt Repaid	-578M	-3.21B	-1.46B	-1.91B	-6.98B
Issuance of Common Stock	744M	13.05B	104M	150M	247M
Repurchase of Common Stock	-12.31M	-643M	-1.68B	-960M	-1.18B
Common Dividends Paid	-730M	-638M	-913M	-1.6B	-2.76B
Common & Preferred Stock Dividends Paid	-730M	-638M	-913M	-1.6B	-2.76B
Other Financing Activities, Total	-2.79B	-362M	-65.64M	-294M	-112M
Cash from Financing	1.56B	9.89B	-1.72B	-1.28B	-3.94B
Foreign Exchange Rate Adjustments	-33.49M	-81.24M	-79.14M	161M	132M
Net Change in Cash	-534M	5B	-2.05B	-191M	2.02B
Supplemental Items
Cash Income Tax Paid (Refund)	122M	47.92M	166M	202M	604M
Levered Free Cash Flow	-708M	-50M	-3.38B	-2.88B	3.58B
Unlevered Free Cash Flow	-628M	72.52M	-3.3B	-2.78B	3.7B
Change In Net Working Capital	774M	640M	1.2B	1.29B	927M
Net Debt Issued / Repaid	4.35B	-1.52B	825M	1.43B	-138M

Fiscal Period: December	2019	2020	2021	2022	2023
Profitability
Return on Assets	5.85	5.12	5.36	9.54	9.95
Return on Total Capital	7.34	6.44	6.79	11.93	12.08
Return On Equity %	10.75	11.91	14.37	20.78	18.94
Return on Common Equity	10.6	11.86	14.36	20.72	18.89
Margin Analysis
Gross Profit Margin %	38.94	37.88	36.14	37.19	41.09
SG&A Margin	14.92	14.68	12.67	9.04	8.87
EBITDA Margin %	23.99	23.48	23.51	26.9	32.24
EBITA Margin %	19.18	19.02	19.32	23.47	27.52
EBIT Margin %	18.88	18.72	18.98	23.24	27.31
Income From Continuing Operations Margin %	14.85	18.06	22.43	22.62	24.05
Net Income Margin %	14.41	17.9	22.26	22.4	23.81
Net Avail. For Common Margin %	14.41	17.86	22.26	22.4	23.81
Normalized Net Income Margin